RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026
- Market cap
- $5.94M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Reviva Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 23, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 18, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 17, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2025 | Sep 19, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 18, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 10, 2024 | Oct 28, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2024 | Sep 17, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2024 | Aug 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |